Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Language
Publication year range
1.
Drug Metab Pharmacokinet ; 46: 100465, 2022 Oct.
Article in English | MEDLINE | ID: mdl-35853340

ABSTRACT

The number of single-nucleotide substitutions of human flavin-containing monooxygenase 3 (FMO3) recorded in mega-databases is increasing. Moreover, phenotype-gene analyses have revealed impaired FMO3 variants associated with the metabolic disorder trimethylaminuria. In this study, four novel amino-acid substituted FMO3 variants, namely p.(Gly191Asp), p.(Glu414Gln), p.(Phe510Ser), and p.(Val530CysfsTer1), were identified in the whole-genome sequences in the Japanese population reference panel (8.3K JPN) of the Tohoku Medical Megabank Organization. Additionally, four variants, namely p.(Ile369Thr), p.(Phe463Val), p.(Arg500Gln), and p.(Ala526Thr) FMO3, were found in the 8.3K JPN database but were already recorded in the National Center for Biotechnology Information database. Novel FMO3 variants p.[(Met1Leu)] and p.[(Trp231Ter)] were also identified in phenotype-gene analyses of 290 unrelated subjects with self-reported malodor. Among the eight recombinant FMO3 variants tested (except for p.[(Met1Leu)] and p.[(Trp231Ter)]), Arg500Gln and Gly191Asp FMO3, respectively, had lower and much lower capacities for trimethylamine and/or benzydamine N-oxygenation activities than wild-type FMO3. Because another FMO3 mutation p.[(Gly191Cys)] with diminished recombinant protein activity was previously detected in two independent probands, Gly191 would appear to be important for FMO3 catalytic function. Analysis of whole-genome sequence data and trimethylaminuria phenotypes revealed missense FMO3 variants that severely impaired FMO3-mediated N-oxygenations in Japanese subjects that could be susceptible to low drug clearances.


Subject(s)
Benzydamine , Humans , Japan , Recombinant Proteins , Nucleotides
2.
Biochem Biophys Res Commun ; 521(3): 555-561, 2020 01 15.
Article in English | MEDLINE | ID: mdl-31677792

ABSTRACT

Uropathogenic Escherichia coli (UPEC) is a major pathogen that causes urinary tract infection (UTI), a common bacterial infectious disease. This bacterium invades the urinary tract cells, where it aggregates, and subsequently forms multicellular colonies termed intracellular bacterial communities (IBCs). The motility of the bacteria plays a key role in the mechanism of virulence in the host bladder. Here, we show that CytR is a modulator of bacterial internalization and aggregation within the bladder epithelial cells sustained by CRP in UPEC. Mutational analyses and gel-shift assays indicated that CytR represses the expression of flhD, thereby encoding a master regulator for flagellar expression that is responsible for bacterial motility when CRP is present, whereas CRP is an activator of flhD expression. Thus, elevated flagellar expression was involved in promoted virulence in the cytR mutant. These combined observations suggest another regulatory layer of flagellar expression and the role of CytR in UPEC virulence.


Subject(s)
Cyclic AMP Receptor Protein/metabolism , Escherichia coli Infections/metabolism , Escherichia coli Proteins/metabolism , Repressor Proteins/metabolism , Urinary Tract Infections/metabolism , Uropathogenic Escherichia coli/physiology , Cell Line , Cyclic AMP Receptor Protein/genetics , Escherichia coli Infections/microbiology , Escherichia coli Proteins/genetics , Gene Deletion , Gene Expression Regulation, Bacterial , Host-Pathogen Interactions , Humans , Repressor Proteins/genetics , Trans-Activators/genetics , Trans-Activators/metabolism , Urinary Bladder/cytology , Urinary Bladder/metabolism , Urinary Bladder/microbiology , Urinary Tract Infections/microbiology , Uropathogenic Escherichia coli/genetics , Uropathogenic Escherichia coli/pathogenicity
SELECTION OF CITATIONS
SEARCH DETAIL